Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ESOMEPRAZOLE\NAPROXEN Cause Dyspnoea? 165 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 165 reports of Dyspnoea have been filed in association with ESOMEPRAZOLE\NAPROXEN. This represents 2.9% of all adverse event reports for ESOMEPRAZOLE\NAPROXEN.

165
Reports of Dyspnoea with ESOMEPRAZOLE\NAPROXEN
2.9%
of all ESOMEPRAZOLE\NAPROXEN reports
17
Deaths
33
Hospitalizations

How Dangerous Is Dyspnoea From ESOMEPRAZOLE\NAPROXEN?

Of the 165 reports, 17 (10.3%) resulted in death, 33 (20.0%) required hospitalization, and 39 (23.6%) were considered life-threatening.

Is Dyspnoea Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ESOMEPRAZOLE\NAPROXEN. However, 165 reports have been filed with the FAERS database.

What Other Side Effects Does ESOMEPRAZOLE\NAPROXEN Cause?

Chronic kidney disease (2,714) Renal failure (2,374) Acute kidney injury (1,120) Death (705) Drug ineffective (459) Off label use (440) Nausea (431) End stage renal disease (349) Tubulointerstitial nephritis (315) Hyperhidrosis (308)

What Other Drugs Cause Dyspnoea?

ALBUTEROL (21,856) TREPROSTINIL (16,348) AMBRISENTAN (13,367) PREDNISONE (12,830) BUDESONIDE\FORMOTEROL (11,158) TIOTROPIUM (10,863) ADALIMUMAB (10,547) DUPILUMAB (10,310) FLUTICASONE\SALMETEROL (9,783) MEPOLIZUMAB (9,192)

Which ESOMEPRAZOLE\NAPROXEN Alternatives Have Lower Dyspnoea Risk?

ESOMEPRAZOLE\NAPROXEN vs ESTAZOLAM ESOMEPRAZOLE\NAPROXEN vs ESTRADIOL ESOMEPRAZOLE\NAPROXEN vs ESTRADIOL CYPIONATE ESOMEPRAZOLE\NAPROXEN vs ESTRADIOL\LEVONORGESTREL ESOMEPRAZOLE\NAPROXEN vs ESTRADIOL\NORETHINDRONE

Related Pages

ESOMEPRAZOLE\NAPROXEN Full Profile All Dyspnoea Reports All Drugs Causing Dyspnoea ESOMEPRAZOLE\NAPROXEN Demographics